Please login or register first to view this content.
News
NEWS
Latest News
Rapid Iloprost Inhalation Improves Pulmonary Vascular Resistance in PAH
Cardiopulmonary Exercise Testing Plus Screening Algorithm Useful in SSc-Related Pulmonary Hypertension
Thinking Outside the Lungs: Extrapulmonary Manifestations in PAH
Baseline Hemodynamic Variables Predictive of Survival in PAH
PH Common in Myeloproliferative Neoplasms, Linked to Diastolic Dysfunction
Treprostinil Approved to Delay Disease Progression in PAH
Selexipag Maintains, Improves WHO Functional Class in PAH
How Long Is the Risk for Pulmonary Embolism Elevated After Surgery?
Postoperative Pulmonary Embolism Risk Elevated for More Than 6 Weeks
Upcoming Meetings
JANUARY 24-26
• 24th Annual International Atrial Fibrillation Symposium
Boston, MA
FEBRUARY 6-8
• International Stroke Conference 2019
Honolulu, HI
FEBRUARY 6-9
• Society for Cardiovascular Magnetic Resonance Joint EuroCMR/SCMR Meeting 2019
Bellevue, WA
FEBRUARY 28- MARCH 1
• Cardiovascular Research Foundation (CRF) Chronic Total Occlusion (CTO) Summit 2019
New York, NY
Drug News from MPR
Cardiometabolic Effects of Gender-Affirming Hormone Therapy in Transgender Youth
Oral Suspension Formulation of Amlodipine Now Available
How I Treat My Patients With Sacubitril/Valsartan for Heart Failure With Reduced Ejection Fraction
Rivaroxaban Appears Safe, Effective for Pediatric Acute VTE
Inclisiran Associated With Sustained LDL-C Reduction in ORION-3 Study
Alirocumab Approved by FDA to Reduce Serious Cardiovascular Event Risk
Is There Evidence to Support Kombucha Health Claims in Humans?
FDA Approves First Generic Versions of Ambrisentan for PAH
Does Ranolazine Potentiate the Effects of ACE Inhibitors, Angiotensin Receptor Blockers?
Icosapent Ethyl Treatment Linked to Significant Reduction in Total CV Events
Want to read more?
Next post in General Cardiology
